ClonOrgan Biotechnology
PrivateLast Round
Series A
Extension
Sep 5, 2025
Total Funding Raised
$8.3M
Company Overview
ClonOrgan Biotechnology operates in Healthcare & Life Sciences and is based in Chengdu. Its latest recorded funding round was a Series A Extension round in September 2025.
ClonOrgan Biotechnology is a biotechnology company that specializes in the research and development of xenotransplantation technologies, including the breeding of gene-edited donor pigs for organ and tissue transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ClonOrgan Biotechnology Comparables
Compare ClonOrgan Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Makana Therapeutics | 78% | |
| eGenesis | 78% | |
| Qihan Biotech | 74% |
For institutional investors. Book with your work email.
ClonOrgan Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 5, 2025 | ||||
| Series A Extension | Jul 4, 2024 | ||||
| Series A | Sep 2, 2021 | ||||
| Early Funding | Dec 1, 2020 | ||||
| Angel | Oct 1, 2018 |
For institutional investors. Book with your work email.
ClonOrgan Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Sangel Venture Capital | Angel |
| YuanBio Venture Capital | Series A Extension |
| Lightspeed China Partners | Series A Extension |
| Luminous Ventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 5, 2025
Led by Lightspeed China Partners with participation from Luminous Ventures and YuanBio Venture Capital.
For institutional investors. Book with your work email.
ClonOrgan Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ClonOrgan Biotechnology's valuation, stock price, and market status.
Is ClonOrgan Biotechnology a public or private company?
ClonOrgan Biotechnology is a private company.
What is the current stock price of ClonOrgan Biotechnology?
ClonOrgan Biotechnology is a private company, so its shares have no public market price. Caplight tracks ClonOrgan Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ClonOrgan Biotechnology worth (valuation)?
Valuation information for ClonOrgan Biotechnology is not publicly available.
Can I buy ClonOrgan Biotechnology stock?
ClonOrgan Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ClonOrgan Biotechnology's last funding round?
ClonOrgan Biotechnology's most recent funding round was Series A Extension on September 5, 2025.
Who are the main investors in ClonOrgan Biotechnology?
Key investors in ClonOrgan Biotechnology include Lightspeed China Partners.
Will ClonOrgan Biotechnology IPO soon?
No public IPO plans have been announced for ClonOrgan Biotechnology.
How can I track ClonOrgan Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in ClonOrgan Biotechnology's shares on secondary markets.